GLP-1 and Heart Health: The Cardiovascular Benefits Beyond Weight Loss

May 24, 2026

GLP-1 and Heart Health: The Cardiovascular Benefits Beyond Weight Loss

By Dr. Onikepe Adegbola, MD PhD — Johns Hopkins-trained physician-scientist and founder of Casa de Sante

Key Takeaways

GLP-1 medications reduce major cardiovascular events by 20-26%. The SELECT trial proved this in patients WITHOUT diabetes — making it the first obesity medication with proven heart benefits.
The cardiovascular benefits appear to be independent of weight loss. Even at doses too low for significant weight reduction, GLP-1 improves endothelial function, reduces arterial inflammation, and lowers CRP.
Blood pressure reductions of 2-5 mmHg systolic are consistent across trials — modest but clinically meaningful over years.
GLP-1 is rapidly becoming a cardiovascular medication that happens to cause weight loss, rather than a weight loss medication that happens to help the heart.

The SELECT Trial: A Game-Changer

Published in November 2023. 17,604 patients with overweight/obesity and established cardiovascular disease but WITHOUT diabetes.
Semaglutide 2.4mg weekly vs. placebo for ~40 months.
Primary outcome: 20% reduction in cardiovascular death, non-fatal heart attack, or non-fatal stroke (MACE).
This was landmark because: (1) it proved cardiovascular benefit in non-diabetic obese patients, (2) it separated the heart benefit from diabetes management, and (3) it changed how cardiologists view obesity treatment.
As a result, the American Heart Association now recognizes GLP-1 as a cardiovascular risk reduction tool, not just a weight loss drug.

How GLP-1 Protects the Heart

Anti-Inflammatory Effects

GLP-1 receptors exist on immune cells. Activation reduces the inflammatory cascades that drive atherosclerotic plaque formation.
CRP (a marker of systemic inflammation) drops significantly on GLP-1 — often by 30-40%.
Inflammation is the driver of plaque rupture (which causes heart attacks). Less inflammation → more stable plaques → fewer heart attacks.

Endothelial Function

The endothelium (inner lining of blood vessels) produces nitric oxide, which dilates vessels and prevents blood clots.
GLP-1 improves endothelial function through increased nitric oxide production, reduced oxidative stress, and decreased endothelin-1 (a vasoconstrictor).
Improved endothelial function → better blood flow, lower blood pressure, reduced clot risk.

Blood Pressure

Mechanisms: weight loss reduces blood volume; natriuretic effects promote sodium excretion; improved endothelial function reduces vascular resistance.
Most patients see 2-5 mmHg systolic reduction. Some patients can reduce or eliminate blood pressure medications.

Lipid Profile

Triglycerides: reduced 15-20% (significant for patients with hypertriglyceridemia)
LDL: modest reduction (5-10%)
HDL: modest increase
The lipid benefits are largely driven by weight loss and reduced visceral fat.

Heart-Healthy Nutrition on GLP-1

The Mediterranean Pattern

The strongest evidence-based diet for cardiovascular protection. Emphasizes: olive oil, fish, vegetables, fruits, nuts, and whole grains. Limits: red meat, processed food, added sugar.
Highly compatible with GLP-1: the reduced appetite allows patients to be more selective about food quality. Choose nutrient-dense Mediterranean foods when appetite is limited.

Omega-3 Priority

EPA and DHA from fatty fish (salmon, mackerel, sardines) reduce triglycerides, stabilize heart rhythm, and reduce inflammation.
Target: 2-3 servings of fatty fish per week, or fish oil supplementation.

Potassium-Rich Foods

Potassium counterbalances sodium → lower blood pressure.
Sources: bananas, potatoes, spinach, oranges, avocado (small amounts for FODMAP sensitivity).

🛒 Heart-Healthy GLP-1 Support

Whey Protein — Whey protein contains bioactive peptides (lactokinins) that act as natural ACE inhibitors — the same mechanism as common blood pressure medications. Regular whey protein consumption is associated with lower blood pressure in clinical studies. Plus, preserving muscle mass on GLP-1 improves metabolic rate and long-term cardiovascular fitness.
Collagen Peptides — The blood vessels themselves are collagen structures. As collagen production declines with age, arterial stiffness increases — a major cardiovascular risk factor. Collagen peptide supplementation has been shown to reduce arterial stiffness in clinical trials. The glycine in collagen also supports glutathione production — the body's primary defense against oxidative damage to blood vessels.
Daily Vitamin — Magnesium for blood pressure regulation and heart rhythm stability. B vitamins to reduce homocysteine (an independent cardiovascular risk factor). CoQ10 and selenium as antioxidants for cardiac cell protection. Foundational support for the cardiovascular system during the metabolic shifts of GLP-1 treatment.

Medical Disclaimer: This article is for educational purposes only. Do not adjust cardiovascular medications without consulting your cardiologist or primary care physician. If you experience chest pain, shortness of breath, or irregular heartbeat, seek immediate medical attention. GLP-1 is not a substitute for prescribed cardiovascular medications. Dr. Adegbola is the founder of Casa de Sante.

Back to blog

Keto. Paleo. No Digestive Triggers. Shop Now

No onion, no garlic – no pain. No gluten, no lactose – no bloat. Low FODMAP certified.

Stop worrying about what you can't eat and start enjoying what you can. No bloat, no pain, no problem.

Our gut friendly keto, paleo and low FODMAP certified products are gluten-free, lactose-free, soy free, no additives, preservatives or fillers and all natural for clean nutrition. Try them today and feel the difference!